Infiltration Completed Phase 4 Trials for Ropivacaine (DB00296)

IndicationStatusPhase
DBCOND0054597 (Infiltration)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02524652Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament ReconstructionTreatment